Navigation Links
Obesity Drug Advertisements Misleading Teens

Advertisements for the weight loss drug Xenical has come under criticism from consumer watchdog, Choice saying that it is misleading young teenage girls//, preying on their fears about their bodies in a breach of advertising guidelines.

The ads have been screened during the high-rating Australian Idol program whose major audiences include 13- to 17-year-olds and have reportedly driven teens as young as 13 and of average weight to seek out the drugs from pharmacies.

Choice said that the ads breached the Therapeutic Goods Advertising Code Council's guidelines prohibiting drug advertising that are directed at people under 18. It has set the call for the withdrawal of the campaign.

Pharmacists have reported increased demands from customers of average weight during the two weeks since the drug has been directly advertised.

One pharmacist on an industry email list wrote, ‘Am I the only one who's noticed a sudden incidence, since the branded advertising started, of people requesting Xenical who have a [body mass index] of 25 or less?’.

"These [mainly female] patients look like they have a healthy weight, yet they're all telling me they want to lose another 5 to 10 kilograms."

Another pharmacist wrote: "I think we are going to be spending a lot of our time sorting out the few people for whom Xenical might be useful from the many who decide they want it, following promotion direct to consumer." However some others have considered that it would do no harm to provide the drug to those with a healthy weight, in spite of its known side effects such as diarrhea and incontinence.

Viola Korczak, the health policy officer at Choice said that the safety and efficacy of Xenical for children had not been established, adding, "Our concern is that parents may not even know that their children are taking these drugs."

Channel Ten markets Australian Idol as the place for advertisers to reach the youth and says the pro gram is able to capture more than 50 per cent of the 16- to 39-year-old audience. Of the 1.48 million people who tuned in on Monday, 320,000 were under 16.

A Ten spokeswoman reported that Xenical was not an Idol sponsor. It was reported to have had booked a small number of ads around the program but had no more planned. She said that the drug's manufacturer, Roche Products, had "cleared all the requisite hurdles" but that "Channel Ten is not in a position to second-guess the rulings of independent regulatory bodies".

David Henry, a professor of clinical pharmacology at the University of Newcastle said that placing the drug ad in the Australian Idol timeslot had everything to do with appearance and very little to do with health.

The complaint is to go before the council on October 19.

If Roche is found to be in breach of the code, it could be forced to withdraw the ad although it would not be fined. The company has denied marketing Xenical to adolescents, saying the advertising was aimed at an older audience.


NL
'"/>




Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Obesity raises IVF miscarriage risk
3. Obesity a risk for pancreatic cancer
4. Obesity shortens lifespan
5. Is Obesity a risk factor?
6. Obesity a global problem
7. Obesity increases health costs
8. Obesity in children a risk factor for diabetes
9. Decrease of Hunger Hormone after Obesity Surgery
10. Obesity risk for immobilized adults
11. Obesity risk can be reduced by eating breakfast regularly
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... ... August 16, 2017 , ... Modern Consulting Insurance & ... program. Partnering once again with Boys & Girls Clubs of Greater Kansas City, ... area’s very own American Idol. With all proceeds benefitting local worthy causes, donations ...
(Date:8/16/2017)... ... August 16, 2017 , ... The ... a three-year grant totaling $975,000, renewing its funding from the Health Resources and ... , This funding marks, the fourth time the HRSA administration has renewed its ...
(Date:8/16/2017)... ... 16, 2017 , ... LabRoots , the leading provider of educational and ... excited to announce Andrew Ly as the winner of the LabRoots Summer Textbook scholarship, ... , Ly, who is in his third year at the University of California, Los ...
(Date:8/16/2017)... ... , ... With a new PD diagnosis every nine minutes, research is critical ... are awarded through a competitive application process and reviewed by APDA’s Scientific Advisory Board ... in all areas relevant to PD research. The SAB meets annually to review ...
(Date:8/16/2017)... NY (PRWEB) , ... August 16, 2017 , ... Melbourne’s ... year by the prestigious Economist Intelligence Unit’s (EIU) annual Liveability Index. , The Index ... , Since the index began in 2006, Melbourne has consistently come in the top ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 million and ... operations Second-quarter 2017 Branded ... Second-quarter 2017 Sterile Injectables ... Second-quarter 2017 adjusted diluted earnings per ... $0.93 Second-quarter 2017 reported ...
(Date:8/7/2017)... Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent specialty pharmacy, ...  All comparisons, unless otherwise noted, are to the quarter ended ... Second Quarter 2017 Highlights include: Revenue ... 3.5% Total prescriptions dispensed of 220,000, compared ... 7.6% Gross profit per prescription dispensed ...
(Date:8/3/2017)... Aug. 3, 2017  Opioid addiction and other drugs ... healthcare costs and threatening outcomes, were problems taken on ... IVD industry that support them, met this week. This ... said that drugs of abuse, procalcitonin and acute kidney ... the organization,s 69th meeting in San Diego, ...
Breaking Medicine Technology: